Gevo, Inc. current report, 15 July 2015

Business Context and Reporting Period

This Form 8-K Current Report was filed by Gevo, Inc. on July 17, 2015, covering events that occurred on July 15, 2015. The filing addresses changes to the Company's Board of Directors, specifically the appointment of a new director and the resignation of an existing director.

Key Financial Metrics

The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance changes and associated compensation arrangements.

Material Changes

  • Appointment of Director: Johannes Minho Roth was appointed as a Class II director effective July 15, 2015. His term expires at the 2018 annual meeting of stockholders.
  • Resignation of Director: Ganesh Kishore resigned from the Board effective immediately on July 15, 2015. He had served since 2008. The resignation is due to time constraints from his role as CEO of the Malaysian Life Sciences Capital Fund and is not the result of any disagreement with the Company.
  • Compensation Arrangements: Mr. Roth will receive an annual retainer of $50,000 in fully vested restricted shares and an annual equity grant valued at $125,000 (restricted shares and/or options) vesting over three years.

Guidance, Outlook, and Risks

The filing contains no financial guidance, operational outlook, or discussion of material risks and contingencies. It notes that Dr. Kishore will continue to advise the Board as his schedule permits. The Company issued a press release regarding these changes, which is attached as an exhibit.

Key Facts for Investor Verification

  • Verify the total equity compensation cost associated with Mr. Roth's appointment ($175,000 annual value) and its impact on the Company's stock incentive plan.
  • Confirm the composition of the Board following Dr. Kishore's departure and the potential impact on the Company's strategic direction given his long tenure since 2008.
  • Review the attached press release (Exhibit 99.1) for additional context on the Board's rationale for these changes.